NeoChord Announces Successful Completion of First Beating Heart Repair Procedures in China

ST. LOUIS PARK, Minn., Sept. 03, 2018 (GLOBE NEWSWIRE) — NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, today announced that it has successfully treated the first patients in Asia using the NeoChord procedure at Queen Mary Hospital in Hong Kong.

Full article:

This entry was posted in MVP in the news, New Research by Lorelei Logsdon. Bookmark the permalink.

About Lorelei Logsdon

I have been diagnosed with MVP for over 20 years. I started a large informational and support Web site for MVPS patients in 1997, which is now I am a professional writer, with a bachelor’s degree in Communication Studies and a master’s degree in English. I currently live in North Carolina with my husband, son, and a spoiled little Chihuahua.

Comments are closed.